Indication

Corpus luteum insufficiency syndrome

Corpus luteum insufficiency syndrome, clinically known as luteal phase deficiency or insufficiency, is an endocrine disorder of the female reproductive system characterized by inadequate progesterone production or shortened lifespan of the corpus luteum following ovulation. Read more about Corpus luteum insufficiency syndrome

4 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Corpus luteum insufficiency syndrome therapies.

Showing 1–4 of 4 drugs

Filter & compare in the drug finder →Opens the drug finder with Corpus luteum insufficiency syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Corpus luteum insufficiency syndrome.

Corpus luteum insufficiency syndrome, clinically known as luteal phase deficiency or insufficiency, is an endocrine disorder of the female reproductive system characterized by inadequate progesterone production or shortened lifespan of the corpus luteum following ovulation.

This insufficient hormonal output disrupts normal secretory transformation of the endometrium, compromising the window of uterine receptivity required for blastocyst implantation.

Primarily affecting women of reproductive age, the condition manifests clinically with abnormal uterine bleeding, shortened luteal phases lasting ten days or fewer, unexplained infertility, and recurrent early pregnancy loss.

Pathophysiologically, it arises from hypothalamic-pituitary-ovarian axis dysregulation, abnormal folliculogenesis, suboptimal luteinizing hormone pulsatility, or defective luteal vascularization.

Personalize your experience

Follow Corpus luteum insufficiency syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it